NVS - Novartis AG

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue53,166,00050,135,00049,386,00050,387,000
Cost of Revenue17,086,00016,958,00017,338,00017,404,000
Gross Profit36,080,00033,177,00032,048,00032,983,000
Operating Expenses
Research Development8,871,0008,510,0008,445,0008,935,000
Selling General and Administrative16,429,00015,000,00014,111,00014,247,000
Non Recurring----
Others485,000614,000405,000824,000
Total Operating Expenses42,871,00041,082,00040,299,00041,410,000
Operating Income or Loss10,295,0009,053,0009,087,0008,977,000
Income from Continuing Operations
Total Other Income/Expenses Net3,540,000-54,000-1,270,000-843,000
Earnings Before Interest and Taxes10,295,0009,053,0009,087,0008,977,000
Interest Expense-957,000-777,000-707,000-655,000
Income Before Tax13,835,0008,999,0007,817,0008,134,000
Income Tax Expense1,221,0001,296,0001,119,0001,106,000
Minority Interest78,00059,00059,00076,000
Net Income From Continuing Ops12,614,0007,703,0006,698,0007,028,000
Non-recurring Events
Discontinued Operations---10,766,000
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income12,611,0007,703,0006,712,00017,783,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares12,611,0007,703,0006,712,00017,783,000